Ownership profile
Who owns Thorne?
Thorne is currently owned by private equity firm L Catterton, which took the brand private in 2023 for $680 million; however, Procter & Gamble announced a $3.8 billion acquisition on August 4, 2026, expected to close in Q4 2026 — after which Thorne will become a subsidiary of a publicly traded consumer goods giant, ending its private equity chapter.
Ownership profile
Thorne
Thorne HealthTech, Inc.
Evidence (9)
Thorne was founded in 1984 and went public on NASDAQ (ticker: THRN) in late 2021 at a valuation of approximately $525 million.
https://www.cnbc.com/2026/08/04/procter-gamble-will-acquire-supplements-brand-thorne.htmlOn August 4, 2026, Procter & Gamble announced a definitive agreement to acquire Thorne from L Catterton for $3.8 billion in cash.
https://www.cnbc.com/2026/08/04/procter-gamble-will-acquire-supplements-brand-thorne.htmlP&G's own SEC 10-K filing (FY2026) confirms the August 4, 2026 agreement to acquire Thorne for $3.8 billion, with closing anticipated in Q2 of P&G's fiscal year 2027, subject to regulatory approval.
https://www.sec.gov/Archives/edgar/data/0000080424/000008042426000103/pg-20260630.htmL Catterton's own press release announced the sale of Thorne to P&G, with the all-cash transaction expected to close in Q4 2026.
https://www.stocktitan.net/news/PG/l-catterton-announces-sale-of-thorne-to-the-procter-gamble-company-y6lgljv6ng2w.htmlL Catterton took Thorne HealthTech private in October 2023 in a deal valued at approximately $680 million ($10.20 per share), acquiring all outstanding shares and delisting the company.
https://www.thorne.com/press-releases/thorne-healthtech-inc-enters-into-definitive-agreement-to-be-acquired-by-l-catterton-for-10-20-per-share-in-cashL Catterton is a consumer-focused private equity firm managing approximately $34 billion of equity capital across private equity, credit, and real estate platforms.
https://beautymatter.com/articles/l-catterton-to-take-thorne-health-tech-privateAs of the investigation date (October 13, 2026), the P&G acquisition had not yet formally closed; L Catterton remains the legal owner pending regulatory clearance.
https://whoistheownerof.com/who-owns-thorne-supplements-ownership-2026/Thorne's annual revenue surpassed $500 million in 2025, and L Catterton is projected to realise a ~77% rate of return on its 2023 investment from the P&G sale.
https://www.newhope.com/industry-news/industry-experts-analyze-proctor-gamble-acquisition-thorneP&G is buying Thorne specifically from L Catterton's Flagship Fund.
https://apexpwr.com/thorne-procter-gamble-acquisition-what-it-means/What's uncertain
- As of October 13, 2026, the P&G acquisition has been announced but not confirmed closed; L Catterton's Flagship Fund remains the legal owner. Once the deal closes, pe_involvement should be updated to 'exited' with full confidence and structure should change to 'corporate' (subsidiary of NYSE-listed P&G).
- The structure is currently scored 'private' because Thorne HealthTech was taken private by L Catterton in 2023 and has not re-listed; the pending P&G transaction has not yet completed.
- pe_involvement is scored 'exited' prospectively because the sale is agreed and announced with a signed definitive agreement; however, this should be treated as forward-looking until official close confirmation is published.
- No state registry or OpenCorporates filing was independently reviewed for the current private entity structure post-2023 take-private.